Sohini Das
 "Sohini Das")
Sohini Das
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das
Pharma and health Q2 preview: Revenue shows growth on domestic, exports
Hospitals and Diagnostics growth is lower due to lesser seasonal illnesses
 "Pharma and health Q2 preview: Revenue shows growth on domestic, exports")
This is the start of Hyundai India's next phase of growth: Tarun Garg
Hyundai veteran Tarun Garg will succeed Unsoo Kim as MD & CEO from Jan 1, 2026, marking a new chapter in the automaker's India journey
 "This is the start of Hyundai India's next phase of growth: Tarun Garg")
Q2 results preview: Robust volumes likely drove auto sector growth
But margins may have lost traction due to higher discounts, ad spends
 "Q2 results preview: Robust volumes likely drove auto sector growth")
Electric PV sales more than double in September; Tata Motors leads
New entrant Tesla also retailed 64 vehicles in September, data from the Federation of Automobile Dealers Associations (Fada) showed
 "Electric PV sales more than double in September; Tata Motors leads")
A deadly dose of neglect: Bitter truth behind cough syrup scare
Bottled negligence: DEG contamination exposes gaps in inspections, leaving pharma units from Gujarat to Kerala under the microscope
 "A deadly dose of neglect: Bitter truth behind cough syrup scare")
Super-specialty hospitals may benefit from CGHS rate revision: Analysts
The new rules introduce a multi-dimensional rate structure based on three key parameters
 "Super-specialty hospitals may benefit from CGHS rate revision: Analysts")
Mercedes clocks best ever Navaratri with retail sales of 2,500 cars
After a sluggish July-August, Mercedes-Benz India posts record Navratri sales on GST cut boost; entry-level models lag but GLA under Rs 50 lakh may revive demand
 "Mercedes clocks best ever Navaratri with retail sales of 2,500 cars")
Analysts expect Indian drugmakers to strike US deals to avoid tariff blow
If Sun Pharma is able to strike a Pfizer-like deal, it may avoid US tariff in near term, say experts
 "Analysts expect Indian drugmakers to strike US deals to avoid tariff blow")
Tata Motors stock may face near-term volatility post demerger: Analysts
Analysts expect Tata Motors' stock to face near-term volatility after the PV-CV demerger, with JLR's production resumption and festive demand outlook key monitorables
TaMo invests ₹120 cr in Freight Tiger, raises total commitment to ₹270 cr
Tata Motors raised its Freight Tiger investment to Rs 270 crore with a fresh Rs 120 crore infusion, lifting its stake to 42-46 per cent to back AI-led logistics solutions
 "TaMo invests ₹120 cr in Freight Tiger, raises total commitment to ₹270 cr")
M&M to sell Finnish subsidiary Sampo Rosenlew to TERA for ₹52 crore
Mahindra & Mahindra will divest its Finnish arm Sampo Rosenlew Oy, maker of combine harvesters and forestry machines, to TERA for Rs 52 crore under a share purchase agreement
 "M&M to sell Finnish subsidiary Sampo Rosenlew to TERA for ₹52 crore")
Tariff uncertainties may spur rise in third-party pharma manufacturing
Analysts say Indian drugmakers may lean on CDMOs, US plants and diversification to safeguard high-value products as Trump's 100% tariff threat looms over patented drugs
Indian pharma firms likely to dodge immediate impact of Trump's tariff
Trump's 100% tariffs on branded drugs will spare Indian generics, though analysts see exposure for Sun Pharma, Biocon and Aurobindo, with Jubilant Pharmova set to benefit
 "Indian pharma firms likely to dodge immediate impact of Trump's tariff")
Skoda brings back Octavia in India; only 100 units up for sale in 2025
Skoda Auto India will reintroduce its high-end Octavia RS as a fully built import next month, with limited units and pre-bookings starting October 6 alongside network expansion
 "Skoda brings back Octavia in India; only 100 units up for sale in 2025")
JLR India operations remain unaffected by UK plant shutdown, cyber-attack
Jaguar Land Rover's India operations are not impacted by UK plant shutdowns after cyber-attacks, with sufficient inventory supporting demand for cars and spare parts
 "JLR India operations remain unaffected by UK plant shutdown, cyber-attack")
TVS Motor to acquire Engines Engineering as it sets up global design centre
TVS has come a long way from being just a strong domestic manufacturer. The company's two-wheeler exports grew significantly by 22.8 per cent in FY25, reaching 1.09 million units
 "TVS Motor to acquire Engines Engineering as it sets up global design centre")
Car dealers take ₹2.5K cr cess blow, turn to original equipment makers
Industry estimates impact for every dealer at ₹3-5 crore
 "Car dealers take ₹2.5K cr cess blow, turn to original equipment makers")
GST reforms: Tax cut and 'Navaratri' bring cheer to car showrooms
Maruti Suzuki got 80,000 enquiries and delivered over 25,000 cars
 "GST reforms: Tax cut and 'Navaratri' bring cheer to car showrooms")
Small cars drive India's PV export growth amid fall in domestic sales
Maruti's top five models for exports in FY26 are Fronx, Jimny, Swift, Baleno and Dzire with the top five markets being Japan, West Asia, Africa, and Latin America
 "Small cars drive India's PV export growth amid fall in domestic sales")
GST reforms: New regime, but old problems persist for car dealers
With new GST rates kicking in, auto dealers face uncertainty on recovering compensation cess from unsold stock, even as OEMs cut prices to spur festive demand
 "GST reforms: New regime, but old problems persist for car dealers")
